Skip to main content

Advertisement

Log in

Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia

  • RESEARCH LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M, Tang Y, Zhao Q (2017) Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes. Oncotarget 8(46):81040–81051

    PubMed  PubMed Central  Google Scholar 

  2. Krishnan AV, Trump DL, Johnson CS, Feldman D (2010) The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am 39(2):401–418

    Article  CAS  Google Scholar 

  3. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, Soni M (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12(10):976–989

    Article  CAS  Google Scholar 

  4. Fang S, Sui D, Wang Y, Liu H, Chiang YJ, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Wargo J, Hu MI, Gardner JM, Reveille JD, Bassett RL, Wei Q, Amos CI, Lee JE (2016) Association of vitamin D levels with outcome in patients with melanoma after adjustment for C-reactive protein. J Clin Oncol 34(15):1741–1747

    Article  CAS  Google Scholar 

  5. Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW (2015) Low serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studies. J Clin Oncol 33(13):1482–1490

    Article  CAS  Google Scholar 

  6. Bittenberrg JT, Neumann F, Altmann B, Achenbach M, Reichrath J, Ziepert M et al (2014) Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab. J Clin Oncol 32(29):3242–3248

    Article  CAS  Google Scholar 

  7. Shah K, Parikh S, Rawal R (2016) Tyrosine kinase inhibitors in Ph+ chronic myeloid leukemia therapy: a review. Asian Pac J Cancer Prev 17(7):3025–3033

    PubMed  Google Scholar 

  8. Ilander M, Kreutzman A, Mustjoki S (2014) IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia. Oncoimmun 3:e28781

    Article  Google Scholar 

  9. Holick MF, Binkley NC, Bisschoff-Ferrari HA et al (2011) Evalutation, treatment, and prevention of vitamin D deficiency: endocrine society clinical guideline. J Clin Endocrinol Metab 96:1911–1930

    Article  CAS  Google Scholar 

  10. Rosen CJ, Abrams SA, Aloia JF et al (2012) IOM committee members respond to endocrine society vitamin D guideline. J Clin Endocrinol Metab 97(4):1146–1152

    Article  CAS  Google Scholar 

  11. Schoenmakers I, Goldberg GR, Prentice A (2008) Abundant sunshine and vitamin D deficiency. Br J Nutr 99(6):1171–1173

    Article  CAS  Google Scholar 

  12. Saito M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Saga A, Musashi M, Kato T, Meguro T, Tanino M (2014) Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Rinsho Ketsueki 55(1):130–132 (in Japanese)

    PubMed  Google Scholar 

  13. Kmira Z, Nesrine BS, Houneida Z, Wafa BF, Aida S, Yosra BY, Monia Z, Sriha B, Abderrahim K (2013) Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use. World J Gastrointest Pathophysiol 4(3):59–62

    Article  Google Scholar 

  14. Campiotti L, Suter MB, Bolzacchini E, Uccella S, Grandi AM, Guasti L (2017) Colitis and chronic bleeding in patients treated with dasatinib. J Cancer Res Ther 5(5):32–33

    Article  Google Scholar 

Download references

Funding

No funding source financed this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonardo Campiotti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

The study was approved by local institution.

Informed consent

Every patients signed informed consensus.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campiotti, L., Bolzacchini, E., Sutter, M.B. et al. Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia. Intern Emerg Med 13, 1337–1339 (2018). https://doi.org/10.1007/s11739-018-1957-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-018-1957-0

Navigation